The OPTN gene helps cells clear damaged proteins and keep inflammation under better control, which is especially important for nerve cells. If the OPTN gene does not work well, waste can build up inside cells and cell stress can rise, which may contribute to some forms of glaucoma or amyotrophic lateral sclerosis (ALS). Many variants in this gene have little effect, while a smaller number are linked to disease.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, the parts of cells that do the work. Others mainly help determine when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
OPTNGene function
What if the gene works
The OPTN gene helps cells recycle old parts and manage some immune signals. It also supports nerve cell health by helping move materials inside cells and clear debris.
Risk
What if the gene does not work
Variants in the OPTN gene are linked to some forms of normal-tension glaucoma and, more rarely, amyotrophic lateral sclerosis. Effects range from milder to more severe, which can influence when symptoms begin and which features appear.
Treatment
What does that mean for your treatment
No treatment or drug choice approach specific to the OPTN gene is currently established in clinical guidelines. The OPTN gene is being studied in amyotrophic lateral sclerosis research as a possible marker of disease biology and treatment target, but this has not yet changed routine care.
Conditions associated with OPTN
Gene function
What if the gene works
Inside your cells, the OPTN gene helps manage routine cleanup, transport, and signaling. Its protein acts like a connector, linking worn cell material to the systems that move or recycle it. This helps explain how the OPTN gene helps cells clear damaged parts as part of normal daily upkeep.
The OPTN gene helps recognize cell material already marked for recycling. Its protein links that material to autophagy (the process cells use to break down and reuse worn parts).
It also helps cells remove damaged mitochondria, the parts that make most of a cell’s energy. Clearing worn mitochondria supports steady energy use and helps keep the cell’s contents balanced.
The OPTN gene helps move proteins and membranes between compartments inside the cell. This supports normal traffic near the Golgi apparatus (the cell’s packaging center) and helps direct cargo to the right place.
Its protein helps organize signals involved in inflammation and responses to stress or infection. By acting as a scaffold (a holding platform), it helps cells pass messages in a more controlled way.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
OPTN gene variants can change the shape, stability, or amount of optineurin, the protein made from the OPTN gene. Some create an early stop signal, so little or no full protein is produced, while others alter binding sites and weaken key protein interactions. These OPTN gene variants and protein function changes can be mild or more disruptive, and larger losses of function are more often linked with stronger effects, including in established OPTN-related eye or nerve disease.
How variants are linked to conditions
Rare pathogenic variants in the OPTN gene can cause some inherited forms of amyotrophic lateral sclerosis, often called ALS. OPTN gene variants are also linked to certain cases of primary open-angle glaucoma, especially normal-tension glaucoma. These findings mainly involve uncommon variants, while more common genetic differences in this gene do not by themselves predict whether someone will develop either condition.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce health risk related to the OPTN gene. Risk can vary by the exact gene change and the condition involved, so anyone worried about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of OPTN variants
The inheritance pattern for OPTN-related conditions can differ depending on the specific condition and variant, so how OPTN variants are inherited is not always the same. Some well-established OPTN-related conditions are inherited in an autosomal dominant pattern, where one altered copy can be enough to play a role. Others have been reported in an autosomal recessive pattern, where a child inherits one altered copy from each parent. Because the OPTN gene is on chromosome 10, variants can be passed to children of any sex.
What does my OPTN result mean for my family?
For OPTN, what this means for family members depends on the specific condition and the exact result. Some OPTN-related conditions can run in families when one changed copy is enough, while others are linked to changes in both copies, which can mean relatives are healthy carriers. Because of that, close family members may also carry the same change and may want to discuss family testing.
Genetic information
Genetic testing
How you find out about variants
OPTN genetic testing looks for DNA variants in a blood or saliva sample. A lab reads the OPTN gene through a single gene test, a broader inherited nerve disease panel, or sometimes whole exome sequencing. Results may show a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the OPTN gene may be worth considering if you or close relatives have ALS, a nerve disease that affects movement, especially if several family members are affected or symptoms started at a younger age. OPTN is usually checked as part of a broader inherited ALS test rather than on its own.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but the amount it reveals varies with the condition and the kind of variant. Factors including lifestyle, environment, age, and medical history also influence how the body functions over time. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, it can also help explain personal experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, have less effect in another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. By looking at connections between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the OPTN gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dosing, so questions about symptoms, treatment plans, or medicine side effects are best discussed with your doctor or pharmacist.
History
The OPTN gene entered medical research in the late 1990s, when scientists first identified it while studying proteins involved in cell signaling. A few years later, interest grew when variants in the OPTN gene were linked to some cases of normal tension glaucoma, an eye condition that can damage vision even when eye pressure is not high. From these first observations, research expanded steadily. In 2010, the gene gained wider scientific attention after studies connected certain OPTN variants with some inherited forms of amyotrophic lateral sclerosis, also called ALS. These findings made the OPTN gene part of a broader effort to understand why some nerve and eye conditions run in families.